• Junaid T Yasin, Amy E Leader, Alison Petok, Gregory Garber, Britainy Stephens, and Brooke Worster.
• College of Population Health, Thomas Jefferson University, College of Population health, Philadelphia, Pennsylvania.
• J Opioid Manag. 2019 Jul 1; 15 (4): 272-274.

ObjectiveTo determine the utility of the screener and opioid assessment for patients with pain-revised (SOAPP-R) for patients with cancer-related pain.DesignThe authors performed a retrospective analysis of cancer patients screened with the SOAPP-R. Opiate abuse was determined using a combination of urine drug screens and analysis of patients' electronic medical records.Setting/PatientsPatients who were seen at a palliative care clinic presenting with pain or needing an opioid prescription at an academic medical center with any type of cancer were screened using the SOAPP-R (N = 69).Outcome MeasuresAberrant opioid-related behavior was determined using a combination of provider notes and urine drug screens.ResultsA positive SOAPP-R score (⩾18) was observed in 27 participants (39.1 percent). The sensitivity and specificity of the SOAPP-R in the study population was 0.75 and 0.80, respectively.ConclusionsThe SOAPP-R, in its current form, may have value in screening patients with cancer for substance abuse. Incorporation of the screening tool in palliative and oncology settings may help reduce opioid abuse in cancer patients.

21 keywords...

hide…